How do the three active ingredients in Delstrigo inhibit HIV-1 replication?

In Delstrigo, doravirine non-competitively inhibits HIV-1 reverse transcriptase, lamivudine’s active triphosphate terminates DNA chains after incorporation, and tenofovir disoproxil, converted to tenofovir diphosphate, competes with deoxyadenosine triphosphate for reverse transcriptase and terminates DNA chains after incorporation.